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In Brief
Almeida et al. find that the balance
between axon demand and myelin
production in the CNS regulates myelin
targeting. In the developing CNS, when
normal target axons are reduced,
oligodendrocyte number increased, or
myelin production per oligodendrocyte
increased, myelin is mistargeted to cell
bodies, including those of neurons.
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The correct targeting of myelin is essential for ner-
vous system formation and function. Oligodendro-
cytes in the CNS myelinate some axons, but not
others, and do not myelinate structures including
cell bodies and dendrites [1]. Recent studies indi-
cate that extrinsic signals, such as neuronal activity
[2, 3] and cell adhesion molecules [4], can bias
myelination toward some axons and away from
cell bodies and dendrites, indicating that, in vivo,
neuronal and axonal cues regulate myelin targeting.
In vitro, however, oligodendrocytes have an intrinsic
propensity to myelinate [5–7] and can promiscu-
ously wrap inert synthetic structures resembling
neuronal processes [8, 9] or cell bodies [4]. A current
therapeutic goal for the treatment of demyelinating
diseases is to greatly promote oligodendrogenesis
[10–13]; thus, it is important to test how accurately
extrinsic signals regulate the oligodendrocyte’s
intrinsic program of myelination in vivo. Here, we
test the hypothesis that neurons regulate myelina-
tion with sufficient stringency to always ensure cor-
rect targeting. Surprisingly, however, we find that
myelin targeting in vivo is not very stringent and
that mistargeting occurs readily when oligodendro-
cyte and myelin supply exceed axonal demand.
We find that myelin is mistargeted to neuronal
cell bodies in zebrafish mutants with fewer axons
and independently in drug-treated zebrafish with
increased oligodendrogenesis. Additionally, by
increasing myelin production of oligodendrocytes
in zebrafish and mice, we find that excess myelin is
also inappropriately targeted to cell bodies. Our
results suggest that balancing oligodendrocyte-
intrinsic programs of myelin supply with axonal
demand is essential for correct myelin targeting
in vivo and highlight potential liabilities of strongly
promoting oligodendrogenesis.1296 Current Biology 28, 1296–1305, April 23, 2018 ª 2018 The Auth
This is an open access article under the CC BY license (http://creativeRESULTS AND DISCUSSION
Oligodendrocytes Mistarget Myelin to Neuron Cell
Bodies when Target Axon Number Is Reduced
Oligodendrocytes target myelin promiscuously in vitro [4, 8, 14],
but in vivo, CNS myelin is selectively targeted to specific axons
and not to dendrites or cell bodies [1]. Our previous live-imaging
studies indicate that oligodendrocytes can retract newly formed
myelin sheaths [15] and that axons can regulate the myelinating
capacity of oligodendrocytes [16]. These observations led us to
hypothesize that axons would always regulate myelination with
sufficient stringency to ensure correct targeting. To test this
prediction, we first analyzed myelination in an environment
with a reduced number of target axons. Reticulospinal axons,
the first myelinated in the zebrafish CNS, do not elongate
completely along the ventral spinal cord of kif1-binding protein
(kif1bp) mutants [17], leading to a 50%–80% reduction of retic-
ulospinal axonal surface in the anterior and posterior spinal
cord, respectively [18]. However, kif1bpmutants have a normal
number of oligodendrocytes in the anterior spinal cord and
about 54% of oligodendrocytes in the posterior (Figures 1A
and 1B), creating a surplus of oligodendrocytes relative to
target axons.
To analyze myelin targeting in kif1bp mutants, we crossed the
myelin reporter line Tg(mbp:EGFP-CAAX) with the Tg(mbp:EGFP)
line, in which all myelinating glia express cytoplasmic EGFP [16].
Strikingly, we observed unusual circular profiles in addition to
normal-appearing myelin sheaths throughout the mutant spinal
cord at 4 days post-fertilization (dpf) (Figures 1A and 1C), To test
the possibility that these structures represented ectopically
myelinated cell bodies, we crossed the Tg(mbp:EGFP-CAAX)
line with the Tg(cntn1b:mCherry) line, in which many spinal neu-
rons express cytoplasmic mCherry [15]. In kif1bp mutants, we
readily identified mCherry-positive neuron cell bodies that were
ectopically wrapped by EGFP-CAAX-positive oligodendrocyte
membrane (Figure1D;MovieS1).To furthercharacterize theseen-
sheathing profiles, we carried out electron microscopy of kif1bp
mutants and readily identified cell bodies enwrapped with
myelin-like membrane (Figure 1F). Thus, contrary to our predic-
tion, when oligodendrocytes are present in excess of axons,
they mistarget myelin to neuronal cell bodies, suggesting that
myelin targeting is not always stringently regulated.or(s). Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. Oligodendrocytes in Excess of Target Axons Ectopically Myelinate Neuronal Cell Bodies in kif1bp Mutants
(A) Double myelin and oligodendrocyte reporter showing oligodendrocytes (asterisks) and ectopic profiles (arrowheads) in the spinal cord (4 dpf).
(B) Oligodendrocyte number (per 100 mm length of spinal cord) is normal in the anterior but reduced in the posterior spinal cord of kif1bp mutants (p = 0.688
anterior; p = 0.0001 posterior; n = 11 wild-type [WT] and n = 11 mutants; t test).
(C) Profile number is increased in mutants (p = 0.018 anterior; p = 0.011 posterior; n = 11 WT and n = 11 mutants; t test).
(D) Double myelin and neuronal reporter showing mCherry+ neurons enwrapped by EGFP+ myelin (arrowheads) in 4 dpf mutants. Asterisk, oligodendrocyte cell
body.
(E) Time course of double oligodendrocyte and myelin reporter in kif1bp mutant. Asterisks denote new oligodendrocytes.
(F) Transmission electron microscopy (TEM) of a typical unmyelinated cell body and four myelinated cell bodies in 6 dpf mutants.
(legend continued on next page)
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Incomplete Correction of Myelin Mistargeting in kif1bp
Mutants
We previously showed that individual oligodendrocytes initiate
formation of all their myelin sheaths within 5 hr [15]. During
this period, myelinating processes survey the local environment
and decide which axons to myelinate and which structures to
avoid. We performed time-lapse imaging of kif1bp mutants dur-
ing myelin sheath formation, which revealed that the wrapping of
cell bodies occurs concomitantly with the formation of normal
sheaths by oligodendrocytes (Movie S2). After this dynamic
period, individual oligodendrocytes can retract sheaths over
the following days, allowing for refinement and correction of
targeting errors that may have occurred [15]. Therefore, we fol-
lowed the fate of wrapped cell bodies from 4 to 8 dpf (Figure 1E).
In wild-types, we found that 11 out of the 13 profiles observed in
10 animals (sampled from a 900-mm-long stretch of each spinal
cord) at 4 dpf were retracted by 8 dpf (Figure 1E). Interestingly, in
kif1bpmutants, where we observed 78 profiles in 11 animals, 21
were retracted by 8 dpf, but this slightly higher rate of retraction
was only able to correct 27% (21/78) of mistargeted profiles
(Figure 1E). Thus, despite some correction of mistargeting,
this is insufficient to correct abundant errors in kif1bp mutants.
As more oligodendrocytes differentiate, more myelinated cell
bodies emerge in mutants (49 profiles added between 4 and 8
dpf in 11 mutants; Figure 1E), whereas this remains rare in
control (4 added between 4 and 8 dpf), highlighting how tightly
regulated myelin targeting is during normal myelination.
Together, these data suggest that oligodendrocytes have a
drive to produce myelin in vivo as in vitro, even with fewer target
axons, which can result in myelin mistargeting to neuronal cell
bodies.
Increasing Target Axon Number Rescues the Wrapped
Cell Body Phenotype of kif1bp Mutants
We reasoned that, if cell body wrapping is due to an excess of
oligodendrocytes relative to target axons, it should be rescued
by increasing target axon number in kif1bp mutants. To test
this, we injected a morpholino to transiently downregulate
notch1a expression, which generates supernumerary Mauth-
ner neurons possessing very large caliber target axons in the
spinal cord [16] (Figure 1G). This manipulation did not change
oligodendrocyte number (Figure 1H), effectively reducing the
relative discrepancy between oligodendrocyte number and
axonal surface in notch1a morpholino-injected kif1bp mutants
compared to uninjected mutants with just two Mauthner
axons. The number of wrapped cell bodies was restored to
wild-type levels in the anterior spinal cord of mutants with
additional Mauthner axons (Figures 1G and 1I). Importantly,
this rescue did not occur in the posterior spinal cord of kif1bp(G) 4 dpf anterior spinal cord of oligodendrocyte and myelin reporter showing th
additional Mauthner axons (red brackets) when injected with notch1a morpholin
(H) Oligodendrocyte number (normalized to control average) is normal in all conditio
p[kif1bp+notch1aMO-kif1bp] = 0.071; n = 23 WT; n = 18 kif1bp; n = 22 WT+notch1a MO;
(I)Myelinated cell body number (normalized to control average) is increased inmutan
n = 14 WT and n = 6 kif1bp posterior; t tests) and is rescued by additional Mauthn
kif1bp+notch1a MO; t test), but not posterior, spinal cord of mutants (p[kif1bp+notch1
All graphs display mean and SD. OL, oligodendrocyte. The scale bars represent 1
See also Movies S1 and S2.
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grow, ruling out the possibility of a direct role of Notch1a
signaling in rescuing this phenotype (Figure 1I). These results
confirm that it is the mismatch between target axons and
oligodendrocyte number—and not disruption of kif1bp—that
causes the ectopic wrapping of cell bodies.
Myelin Is Not Mistargeted to Small-Caliber
Unmyelinated Axons in kif1bp Mutants
To further assess myelin targeting in kif1bp mutants, we
analyzed individual mbp:EGFP-CAAX-expressing oligodendro-
cytes in the anterior spinal cord (Figure 2A). As expected, individ-
ual oligodendrocytes in mutants myelinated cell bodies more
frequently than wild-type (11/29 cells in mutant animals versus
5/43 in wild-type; Figure 2D; Fisher exact test; p = 0.0187). Inter-
estingly, individual oligodendrocytes made a normal number of
sheaths in kif1bp mutants (Figure 2B), further suggesting that
oligodendrocytes can make myelin sheaths independently of
precise axonal demand. We found that the sheaths made by
oligodendrocytes in kif1bp mutants were targeted to the axonal
tracts that they typically myelinate, i.e., the dorsal tract for dorsal
oligodendrocytes and the ventral tract for ventral oligodendro-
cytes (Figure 2E). Electron microscopy analyses of myelination
in kif1bp mutants indicated that there was no observable in-
crease in the myelination of inappropriate small-caliber axons
(Figures 2F and 2G) and that myelin was restricted to the large-
caliber (>0.4 mm diameter) axons that remained (Figures 2F
and 2G). If most myelin is targeted to the remaining large-caliber
axons in kif1bp mutants, we would expect to see more sheaths
along individual axons and that such sheaths would be shorter
in length. To test this prediction, we assessed myelination along
individual reticulospinal axons using the tagRFPt-cntn1a re-
porter, which is initially localized along the entire axolemma but
becomes excluded from regions with myelin sheaths [3]. We
co-expressed cytoplasmic EGFP and tagRFPt-cntn1a in individ-
ual reticulospinal axons (see STAR Methods) and found that re-
ticulospinal axons in kif1bp mutants had significantly more
tagRFPt-cntn1a gaps (sheaths), which were shorter in length
(Figures 2I–2K). In addition, our analysis of single-oligodendro-
cyte morphology indicated that the average length of myelin
sheaths made per cell was significantly shorter in kif1bpmutants
(Figure 2C). Although we cannot rule out an oligodendrocyte-
autonomous role for kif1bp in regulating myelin sheath length,
our data indicate that the availability of axonal space regulates
correctmyelin targeting. Our data suggest that oligodendrocytes
target myelin in a hierarchical manner, first to large-caliber
axons, as one would predict, and then, surprisingly, to cell
bodies, which are more readily myelinated than inappropriate
small-diameter axons.at increased ectopic profiles (arrows) in mutants are rescued by presence of
o (MO).
ns (p[kif1bp-WT] = 0.267; p[WT+notch1a MO-WT] = 0.483; p[kif1bp+notch1aMO-WT] = 0.374;
n = 19 kif1bp+notch1a MO; t tests).
ts (p[WT-kif1bp] < 0.0001, n = 23WTand n=18 kif1bpanterior; p[WT-kif1bp] = 0.0019,
er axons in anterior (p[kif1bp+notch1a MO-kif1bp] = 0.0008, n = 18 kif1bp and n = 19
a MO-kif1bp] = 0.359, n = 6 kif1bp and n = 5 kif1bp+notch1a MO; t test).
0 mm (A, E, and G), 5 mm (D), 0.5 mm (F, whole cell), and 0.1 mm (F, myelin detail).
Figure 2. Individual Oligodendrocytes in Excess of Target Axons Wrap Cell Bodies and Normal Axon Targets, but Not Incorrect Axons
(A) Individual oligodendrocytes (mbp:EGFP-CAAX+) in the 4 dpf anterior spinal cord. Arrow,myelinated cell body; arrowheads, normal myelin sheaths; red outline,
oligodendrocyte cell body.
(B) Sheath number per oligodendrocyte is normal (p = 0.868 dorsal, n = 14 WT and n = 7 mutants; p = 0.118 ventral, n = 16 WT and n = 9 mutants; t tests).
(C) Average sheath length per oligodendrocyte is reduced in mutants (p = 0.007 dorsal, n = 14 WT and n = 7 mutants; p = 0.013 ventral, n = 16 WT and n = 9
mutants; t tests).
(D) Number of myelinated cell bodies per oligodendrocyte is increased in mutants (p = 0.009, n = 35 WT and n = 25 mutants; Mann-Whitney test).
(E) Proportion of myelin sheaths target axonal tracts in mutants is comparable to wild-type.
(F) TEM at the onset of myelination (3.5 dpf) focusing on the ventral region with reticulospinal axons (e.g., asterisks) and adjacent medial region with small-
diameter (<0.3 mm) unmyelinated axons.
(G) The smallest myelinated axons remain above 0.4 mm diameter (p[0.4–0.5mm] = 0.908; p[0.5–0.7] = 0.251; p[0.7–0.9] = 0.386; p[0.9+] = 0.782; n = 5 WT and n = 5
mutants; corrected t tests).
(legend continued on next page)
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Myelin Is Also Mistargeted to Neuronal Cell Bodies in
Animals with Increased Oligodendrocyte Number
There is currently a major drive to identify compounds that
promote oligodendrocyte differentiation in vivo, given that a
bottleneck in efficient oligodendrocyte differentiation is thought
to limit myelin regeneration in multiple sclerosis [10–12]. Chem-
ical screens have recently identified several compounds that
promote oligodendrocyte differentiation and remyelination in
both toxin and inflammatory models of demyelination [19–23].
We recently completed an analogous chemical discovery screen
in zebrafish that identified further compounds, including
Skp2C25 and C646, inhibitors of Skp2 and p300/CBP, respec-
tively, that promote oligodendrogenesis (J.J.E., K.L.H.C.,
J.M.W., H. Kamadurai, M. Muskavitch, D.A.L., unpublished
data). Treatment with 2 mM Skp2C25 or 2 mM C646 between 2
and 4 dpf (i.e., during oligodendrocyte development and after
most neurogenesis) leads to an increase inmyelinating oligoden-
drocyte number (Figures 3A and 3B). Electron microscopy char-
acterization of the effects of Skp2C25 treatment showed that the
increase in oligodendrocytes results in an increase in myelinated
axons, without affecting axonal number or size (Figures 3E–3H).
These compounds allowed us to independently test whether
increasing oligodendrocyte number relative to target axons
leads to myelin mistargeting. We quantified myelinated cell
bodies as before and found more wrapped cells in both
Skp2C25- and C646-treated animals (Figures 3A and 3C),
many of which are neuronal, as seen in kif1bp mutants (see
Figure S1). Interestingly, the number of wrapped cell bodies
correlated positively with the number of oligodendrocytes in
individual animals, whereby individual animals with a larger in-
crease in oligodendrocytes had a much greater increase in
myelinated cell bodies (Figure 3D). Potentially, a slight increase
in oligodendrocyte number may lead to the production of suffi-
cient myelin to saturate all available myelination-competent
axonal space, a consequence of which would be that a much
larger increase in oligodendrocyte number would lead to a pro-
portionally greater mistargeting of myelin to cell bodies.
We next asked whether excessmyelin in Skp2C25-treated an-
imals, observed by both electron (Figures 3E and 3G) and light
(Figures 3I–3K) microscopy, was solely targeted to the correct
axons (precociously) and inappropriately to cell bodies. Similar
to kif1bp mutants, we found that axons smaller than 0.4 mm in
caliber remained unmyelinated in Skp2C25-treated animals (Fig-
ures 3E and 3H). Indeed, biophysical constraints can regulate
myelination: oligodendrocytes readily myelinate inert fibers, but
only >0.4 mm [8], suggesting that smaller caliber targets may
require additional mechanisms (e.g., increased adhesion) to
ensure their myelination [24]. Therefore, given how readily oligo-
dendrocytes can myelinate inert structures >0.4 mm in vitro, we
predicted that large-caliber axons that are typically not myelin-
ated may become ectopically myelinated when myelin supply
exceeds axonal demand. We assessed myelination along
large-caliber segments of Rohon-Beard axons, which are essen-(H–J) Single EGFP+ reticulospinal axons (H) co-expressing themyelination reporte
sheaths, arrowheads) in the anterior spinal cord of mutants at 4 dpf, quantified in
and n = 5 mutants; t test).
(K) % axon myelinated (tagRFPt-cntn1a negative) is comparable to wild-types (p
All graphs display mean and SD, except (D) (median and interquartile range). The
1300 Current Biology 28, 1296–1305, April 23, 2018tially never myelinated in control [3], despite residing adjacent to
myelinated axons in the dorsal spinal cord and being accessible
to oligodendrocytes. To visualize myelin along Rohon-Beard
(RB) axons, we combined the Tg(isl1:Gal4; UAS:DsRed) animals,
which have fluorescent RB neurons and axons [25], with
Tg(mbp:EGFP-CAAX). We confirmed their very rare myelination
in controls (1 myelin sheath associated with 76 RB neurons in
12 animals; see the example in Figure 3I) and found that this
was not significantly increased in Skp2C25-treated animals (6
myelin sheaths with 96 RBs in 12 animals; Figure 3I; Mann-Whit-
ney test; p = 0.205). These observations show that, although
there may be occasional mistargeting of myelin to incorrect
large-caliber axons, this does not happen readily. Together,
our data indicate that myelin is targeted in a hierarchical fashion
that prioritizes specific large-caliber axons and allows a surpris-
ing degree ofmyelination of cell bodies but rather stringently pre-
vents myelination of incorrect axons, in line with previous studies
that identified negative regulators of myelination [26]. It will be
interesting in the future to determine where in the hierarchy of
myelin targeting dendrites fall, given our previous findings of a
somatodendritic inhibitor of myelination [4].
Decreasing Oligodendrocyte Number Rescues Low
Wild-Type Level of Cell Body Wrapping
In all analyses, we noted a low level of cell body wrapping in con-
trol animals, as we recently reported in mammals [4]. Based on
our observations that the extent of myelin mistargeting corre-
lated positively with the relative excess of oligodendrocytes,
we predicted that animals with a reduced number of oligoden-
drocytes would exhibit little, if any, myelin mistargeting. To
reduce oligodendrocyte number, we treated animals between
1.5 and 4 dpf with GANT61, an inhibitor of Gli1/2, the down-
stream effector of the sonic hedgehog signaling pathway essen-
tial for the generation of oligodendrocytes [27–30]. This treat-
ment reduced oligodendrocyte number below normal and did
indeed reduce the already low number of myelinated cell bodies
below that observed in wild-type (Figures 3A–3D). This result in-
dicates the myelination is normally slightly biased toward slight
overproduction, even at the risk of occasional, usually transient,
mistargeting errors.
Myelin Is Mistargeted to Neuronal Cell Bodies when
Myelin Production by Oligodendrocytes Is Increased
Our results indicate that dysregulation of oligodendrocyte num-
ber relative to target axons can lead to themistargeting ofmyelin.
To test whether regulating the production of myelin by oligoden-
drocytes also influences its targeting, we took advantage of the
observation that overexpressing a constitutively active form of
Akt1 in oligodendrocytes increases myelination [31–33]. We first
co-expressed constitutively active human Akt1 (hAkt1DD) in
myelinating oligodendrocytes in zebrafish by generating the sta-
ble transgenic line Tg(mbp:hAkt1DD). In Tg(mbp:hAkt1DD) ani-
mals at 5 dpf we found a significant increase in the number ofr tagRFPt-cntn1a showing more and shorter tagRFPt-cntn1a gaps (i.e., myelin
(I) (p = 0.003; n = 31 WT and n = 5 mutants; t test), and (J) (p = 0.005; n = 31 WT
= 0.174; n = 31 WT and n = 5 mutants; t test).
scale bars represent 5 mm (A), 0.5 mm (F), and 10 mm (H).
Figure 3. Increasing Oligodendrocyte Number Recapitulates Wrapping of Neuronal Cell Bodies
(A) Double myelin and oligodendrocyte reporter (4 dpf), treated with vehicle DMSO, Skp2C25, or GANT61.
(B and C) Oligodendrocyte (e.g., asterisk) number andmyelinated cell bodies (e.g., arrowheads) number is increased in the dorsal spinal cord of Skp2C25-treated
animals and reduced in GANT61-treated animals, quantified in (B) (p[Skp2C25-DMSO] = 0.0004, n = 20 DMSO and n = 10 Skp2C25; p[C646-DMSO] < 0.0001, n = 22
DMSO and n = 19 C646; p[GANT61-DMSO] < 0.0001, n = 9DMSO and n = 13GANT61; t tests; data normalized to control average) and in (C) (p[Skp2C25-DMSO] < 0.0001,
n = 20 DMSO and n = 10 Skp2C25; p[C646-DMSO] < 0.0001, n = 22 DMSO and n = 19 C646; p[GANT61-DMSO] = 0.011, n = 9 DMSO and n = 13 GANT61; t tests; data
normalized to control average; GANT61 data and its control plotted on right y axis), respectively.
(legend continued on next page)
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wrapped cell bodies (Figures 4A and 4B), with no changes to
oligodendrocyte number (oligodendrocyte number per 100 mm
of dorsal spinal cord: control 6 ± 2; n = 25; versus
Tg(mbp:hAkt1DD) 7 ± 1; n = 14; p = 0.1; t test). Interestingly,
we found that the number of myelin sheaths made per individual
oligodendrocyte was similar in control and Tg(mbp:hAkt1DD) an-
imals, as wasmyelin sheath length at these stages, but that each
oligodendrocyte formed a significantly higher number of myelin-
ated cell bodies (Figures 4C–4F). This analysis indicates that
increasing myelin production can result in direct mistargeting
of myelin to cell bodies.
We next asked whether increasing myelin production in mam-
mals might also result in mistargeting. To test this, we increased
Akt1 signaling in myelinating oligodendrocytes in mice by condi-
tional ablation of PTEN, an inhibitor of the Akt1 pathway, using
CNP-Cre. To assess whether this led to mistargeting of myelin
to cell bodies, we performed MBP and NeuN immunostaining
of cervical spinal cord sections to label myelin and neuron cell
bodies, respectively (Figure 4G). At postnatal day 30 (P30), we
found that the number of NeuN-positive neuronal cell bodies
wrapped by MBP-positive immunostaining in the dorsal horn of
the spinal cord of PTENfl/fl; CNP-Cre animals was significantly
increased compared to PTENfl/fl controls that do not express
Cre (Figures 4G–4I). These data indicate that an imbalance of
myelin supply and axonal demand can also lead to myelin mis-
targeting in mammals.
In sum, we have found that myelination by oligodendrocytes is
normally biased toward slight overproduction in vivo, potentially
to ensure robust myelination of the axons that need it, even if this
results in a low level of (typically transient) myelin mistargeting.
When interactions between axons and myelinating oligodendro-
cytes are dysregulated, and myelin is produced in excess of
target axon demand, significant mistargeting to neuronal cell
bodies can occur. Future studies will determine whether myelin
targeting varies between species, distinct ages, or areas of the
CNS; elucidate when during myelination extrinsic signals regu-
late myelin targeting: during the initial dynamic period of sheath
formation and/or the subsequent period of refinement; and char-
acterize the functional consequences of such mistargeted
myelin on neuronal physiology. It will also be very important to
determine whether compounds that promote oligodendrogene-
sis that are being considered as therapeutic candidates for the
treatment of diseases of myelin [34] could result in myelin
mistargeting and possible functional disruption. Our observa-(D) Plotting all normalized data shows that myelinated cell body number positive
displayed for each treatment).
(E) TEM of 4 dpf medial-dorsal spinal cord shows increased number of myelinate
many unmyelinated large-caliber axons (green circles).
(F) Total number of large-caliber (>0.5 mmdiameter) axons in themedial-dorsal spi
Skp2C25; t test).
(G) Myelinated axon number is increased with Skp2C25 (p = 0.006; n = 8 DMSO
(H) Smallest myelinated axons in Skp2C25-treated animals remain above 0.4 mm
corrected t tests).
(I) 4 dpf double myelin and Rohon-Beard (RB) neuron reporter (Tg(isl1(ss):Gal4; U
(J and K) Skp2C25-treated animals have more ‘‘very dorsal’’ myelin sheaths (arrow
add up to a higher total myelin sheath length, quantified in (K) (p = 0.013; n = 19 D
bodies (arrowheads). Examples of very rare myelin sheaths on dsRed+ large-calib
(see main text for details), are shown.
All graphs display mean and SD. The scale bars represent 20 mm (A) and 10 mm
1302 Current Biology 28, 1296–1305, April 23, 2018tions highlight how finely balanced myelination by oligodendro-
cytes is in the healthy nervous system and where vulnerabilities
in the process of myelination may lie.
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nal cord is normal in Skp2C25-treated animals (p = 0.852; n = 4 DMSO and n = 5
and n = 9 Skp2C25; t test).
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er RB axons (arrows in merged panels), which are not increased with Skp2C25
(I). See also Figure S1.
Figure 4. Increasing Myelin Production Induces Cell Body Wrapping in the Zebrafish and Mouse Spinal Cord
(A) 5 dpf spinal cord of control and transgenic zebrafish overexpressing constitutively active human Akt1 in oligodendrocytes, Tg(mbp:hAkt1DD), in double
oligodendrocyte and myelin reporter line (arrowheads, wrapped cell bodies; asterisks, oligodendrocytes).
(B) The number of wrapped cell bodies is significantly increased in Tg(mbp:hAkt1DD) (p = 0.001; n = 25 control and n = 14 Tg(mbp:hAkt1DD); t test).
(C–F) Individual oligodendrocytes (C; asterisks note their cell bodies; note cytoplasmic TagRFPt expression in Tg(mbp:hAkt1DD) cell in inset) have a similarmyelin
sheath number and length at 5 dpf, quantified in (D) (p = 0.077; n = 16 control and n = 25 Tg(mbp:hAkt1DD); t test) and (E) (p = 0.412; n = 16 control and n = 25
Tg(mbp:hAkt1DD); t test), but Tg(mbp:hAkt1DD) animals have more myelinated cell bodies (arrowheads), quantified in (F) (p = 0.011; n = 21 control and n = 30
Tg(mbp:hAkt1DD); Mann-Whitney test).
(C’) Another example of an individual oligodendrocyte in Tg(mbp:hAkt1DD) showing ectopic myelination of multiple cell bodies (arrowheads; asterisk denotes
oligodendrocyte cell body).
(G) Immunostaining of myelin basic protein (red, MBP) and NeuN (magenta) in the dorsal horn of the cervical spinal cord. Arrowhead indicates a wrapped NeuN+
neuronal cell body.
(H) Optical sections representing 1-mm increments in the axial plane. Rightmost panel is a maximum intensity projection of MBP.
(I) Frequency of ectopic wrapping events is slightly increased in the cervical spinal cord of P30 PTENfl/fl; CNP-Cre transgenic mice (p = 0.029; Mann-Whitney test;
n = 4 animals per genotype; each animal quantified as the median of 6 pooled histological sections).
All graphs display mean and SD, except for (F) and (I), which display median and interquartile range. The scale bars represent 10 mm (A), 5 mm (C and C’), 1 mm
(inset C), 50 mm (G), and 20 mm (H).
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish Lines and Maintenance
All zebrafish were maintained under standard conditions [41, 42] in the Queen’s Medical Research Institute CBS Aquatics facility at
the University of Edinburgh. Studies were carried out with approval from the UK Home Office and according to its regulations, under
project licenses 60/8436 and 70/8436. Adult animals were kept in a 14 hours light and 10 hours dark cycle. Embryos were kept at
28.5C in 10mM HEPES-buffered E3 Embryo medium or conditioned aquarium water with methylene blue. Embryos were staged
according to [43], and analyzed between 2-8 dpf, well before the onset of sexual differentiation in zebrafish.
The following existing mutant and transgenic lines were used: kif1bpst23 [17]; Tg(sox10:mRFP) [35]; Tg(olig2:EGFP) [36];
Tg(mbp:EGFP) [16]; Tg(mbp:EGFP-CAAX) [16]; Tg(cntn1b(5kb):mCherry) [15]; Tg(elavl3:Gal4VP16) [37]; Tg(Xla.Tubb:DsRed)
referred to as Tg(NBT:DsRed) in text [38]; Tg(isl1:Gal4-VP16,UAS:RFP) [25]. The line Tg(mbp:tagRFPt-2A-hAkt1DD) was generated
in this study (see details below). kif1bpst23 animals were genotyped as before [18], using primers st23F2 and st23R2 (Table S1)
followed by digestion of the PCR product with restriction enzyme NmuCI, which cleaves the WT PCR product into 228bp and
22bp fragments, but not the mutant product. In some experiments, kif1bpst23 homozygous mutants were identified by direct visual-
ization of an incompletely grown posterior lateral line nerve in Tg(mbp:EGFP-CAAX) or Tg(sox10:mRFP) larvae. Mutants were
compared towild-type-siblings (‘‘WT’’). Throughout the text including figures, ‘Tg’ denotes a stable, germline inserted transgenic line.
Mouse lines
All mice used in this study were housed and handled with the approval of the University of California, San Francisco Institutional
Animal Care and Use Committee (IACUC). Male and female mice group housed in a 12-hour light/dark cycle with ad libitum access
to food and water and aged to postnatal day 30 were used in all experiments. Ptenfl/fl;CNP-Cre mice were assigned to the experi-
mental group, while Ptenfl/fl;CNP-Cre littermate controls were assigned to the control group. Ptenfl/fl mice were a generous gift
from Dr. Eliott Sherr, and CNP-Cre mice were a generous gift from Dr. Klaus Armin-Nave [44, 45]. Ptenfl/fl and CNP-Cre were gen-
otyped via standard PCR, using primers oIMR9554/oIMR9555 and Puro3/E3sense/EcoIN2, respectively (Table S1).
METHOD DETAILS
Generation of zebrafish with supernumerary Mauthner axons
We generated animals with supernumerary Mauthner neurons as previously described [16], by injection of 500pg of a morpholino
targeting a notch1a-specific splice junction [46] in fertilized eggs between 1-8 cell stage. Successful supernumerary Mauthner
neuron induction was identified by visualizing supernumerary Mauthner axon myelin sheaths with the Tg(mbp:EGFP-CAAX)
transgene.
Generation of EGFP-UAS-tagRFPt-cntn1a axonal myelination reporter
We previously described the axonal reporter EGFP-cntn1a, which labels unmyelinated segments [3]. We replaced the EGFP coding
sequence with that of tagRFPt, by ligating the tagRFPt cDNA amplified with primers tagRFPt-F and tagRFPt-nostop-R (Table S1) to a
Gateway 30-entry vector containing the original EGFP-cntn1a cDNA, amplified with primers cntn1a-F and cntn1a-signal-R (Table S1),
which amplify the whole plasmid except for the EGFP cDNA.We confirmed correct cloning of tagRFPt after the cntn1a signal peptide
by Sanger sequencing. We then recombined this 3E-tagRFPt-cntn1a with a 50-entry vector containing the EGFP coding sequence in
the reverse orientation to that of tagRFPt-cntn1a, a middle-entry vector containing 5 Gal4 binding sites (upstream activating
sequences, UAS) flanked on both sides by E1b minimal promoters in opposite orientations, and destination vector pDestTol2pA2
from the tol2kit [39], using LR Clonase II Plus. This generated the bidirectional, Gal4-dependent construct pTol2-EGFP-UAS-
tagRFPt-cntn1a, where the EGFP and tagRFPt-cntn1a sequences are arranged in a ‘Janus’ configuration, facing ‘away’ from
each other, leading to efficient expression of both reporters in individual cells [47, 48].
Generation of Tg(mbp:tagRFPt-2A-hAkt1DD)
To generate a constitutively-active form of human Akt1 (hAkt1), we first mutagenized the coding sequence of human Akt1 in a
Gateway middle-entry vector, ME-myrhAkt1 (kind gift of Dirk Sieger), to generate the 308D and 473D point mutations (Akt1DD), pre-
viously described to mimic the phosphorylated activated state of Akt1 [49], with primers Akt1-308D-F, Akt1-308D-R, Akt1-473D-F
and Akt1-473D-R (Table S1). We verified successful mutagenesis by Sanger sequencing. We then used recombinant PCR [50, 51] to
generate the coding sequence for tagRFPt-2A-hAkt1DD, wherein the short self-cleaving 2A peptide yields a one-to-one stoichiom-
etry of tagRFPt and hAkt1DD, enabling us to identify the cells expressing hAkt1DD by tagRFPt expression. To do this, we amplified
tagRFPt (without a stop codon) with primers attB1-tagRFPt-F and tagRFPt-2A-R; and amplified hAkt1DD (with a stop codon) with
primers 2A-Akt1-F and attB2R-Akt1-R. We then generated the full length attB1-tagRFPt-2A-hAkt1DD-attB2R using primary PCRCurrent Biology 28, 1296–1305.e1–e5, April 23, 2018 e2
products as templates and the outer flanking primers containing attB sites. We recombined the full length PCR product with
pDONR221 to generate middle entry vector ME-tagRFPt-2A-Akt1DD using BP Clonase, whose sequence we verified by Sanger
sequencing. We then recombined our previously described 50-entry vector 5E-mbp [16], with ME-tagRFPt-2A-Akt1DD and 3E-polyA
and pDestTol2pA2 from the tol2kit, using LR Clonase II Plus. This generated the pTol2-mbp:tagRFPt-2A-hAkt1DD construct, which
yielded tagRFPt-expressing oligodendrocytes when transiently expressed in injected zebrafish embryos.We established a germline-
inserted stable transgenic line by screening for founders derived from co-injection of 1nL of 10 ng/mL pTol2-mbp:tagRFPt-2A-
hAkt1DD plasmid DNA with 50 ng/ml tol2 transposase mRNA. In this line, all oligodendrocytes express tagRFPt and thus hAkt1DD.
For brevity, we refer to this line as Tg(mbp:hAkt1DD) in the main text.
Single cell labeling
To mosaically label oligodendrocytes, we injected fertilized eggs with 1nL of 10ng/mL pTol2-mbp:EGFP-CAAX plasmid DNA and
50ng/ml tol2 transposase mRNA. Animals were screened at 4dpf for isolated oligodendrocytes. To express the myelination reporter
in individual reticulospinal axons, Tg(elavl3:Gal4VP16) fertilized eggs were injected with 1nL of 10ng/mL pTol2-EGFP-UAS-tagRFPt-
cntn1a plasmid DNA and 50ng/ml tol2 transposase mRNA. Animals were screened at 4dpf for EGFP+ and tagRFP-cntn1a+ reticu-
lospinal axons, descending from labeled neurons in the hindbrain, located in the ventral tract of the spinal cord and identified by their
typical collateral branches. Typically only one cell per animal was imaged; whenmore than one cell per animal was imaged, data were
averaged per individual animal.
Transmission electron microscopy
Tissue was prepared for TEM as previously described [18, 52]. Zebrafish embryos were terminally anaesthetised in tricaine and incu-
bated, with microwave stimulation, first in primary fixative (4% paraformaldehyde 2% glutaraldehyde in 0.1M sodium cacodylate
buffer) and then in secondary fixative (2%osmium tetroxide in 0.1M sodium cacodylate/imidazole buffer). Samples were then stained
en bloc with a saturated uranyl acetate solution and dehydrated in an ethanol series and acetone, both with microwave stimulation.
Samples were embedded in EMbed-812 resin (Electron Microscopy Sciences), and sectioned using a Reichert Jung Ultracut Micro-
tome. Sections were cut at comparable somite levels by inspection of blocks under a dissection microscope, and stained in uranyl
acetate and Sato lead stain. TEM images were taken with a Phillips CM120 Biotwin TEM.
Drug Treatments
We sought to treat zebrafish embryos after neurogenesis and axonal outgrowth, but during a period that encompasses all stages of
oligodendrocyte development (from specification of precursors to myelination), in order to bias our treatments to affect oligodendro-
cyte-lineage cells. To this end, we treated zebrafish embryos between 1.5-2dpf and 4dpf. By 2dpf, for example, the majority of motor
neurons have been born in the developing zebrafish spinal cord [53]; andmost reticulospinal axons have reached the posterior end of
the spinal cord [18]; whereas oligodendrocyte precursor specification is just starting (between 36hpf and 48hpf) [18, 35]. We treated
embryos by bath-application of Skp2C25 (2 mM), C646 (2 mM), GANT61 (10 mM from 1.5dpf), all in 1% DMSO, dissolved in HEPES-
buffered embryo medium, or with only 1% DMSO in HEPES-buffered embryo medium as control. Zebrafish larvae tolerated these
treatments well; we selected morphologically normal and healthy animals at 4dpf for subsequent analyses.
Mouse tissue collection and immunostaining
Spinal cord tissuewas collected fromP30mice using standard techniques. Briefly, after transcardial perfusion with PBS and then 4%
PFA (Electron Microscopy Tools), the spinal cord was dissected out and post-fixed in 4% PFA overnight at 4C and cryoprotected by
incubation in 30% sucrose in PBS. Coronal sections were cut in 30-mm thick slices from the cervical spinal cord (C5–C8) using a
freezing microtome (Microm HM 450 and KS 34, Thermo Scientific). Sections were immunostained using standard methods. In brief,
free-floating sections were permeabilized in 20% normal goat serum (NGS) (Sigma-Aldrich) plus 0.1% Triton X-100 (Sigma-Aldrich)
in, followed by an overnight incubation at 4C with primary antibodies in permeabilization solution. Sections were washed in PBS and
incubated with secondary antibodies for 4 hours at room temperature. Subsequently, sections were washed in PBS and then water,
mounted onto glass slides, air-dried, and coverslipped with fluorescent mounting medium (Dako).
Primary antibodies against microtubule-associated protein 2 (chicken anti-MAP2, 1:500,Millipore), MBP (rat anti-MBP, 1:200), and
NeuN (rabbit anti-NeuN, 1:1,000, Abcam) were used for immunostaining. Secondary antibodies were Alexa Fluor raised in goat
against rat, rabbit, or chicken in the following wavelengths: 488, 594, and 647 (1:1,000, Life Technologies), and nuclei were stained
with DAPI.
Live imaging
We live-imaged embryos by anesthetising them with tricaine and mounting them on their side in coverslips, embedded in 1.5% low
melting point agarose. Z stacks were acquired using confocal microscopes Zeiss LSM710 or LSM880 equipped with Airyscanner, or
a Zeiss AxioImager Z1 equipped with an Apotome2 structured illumination unit; and a 20X objective (Zeiss Plan-Apochromat 20x dry,
NA = 0.8), a water-immersion 63x objective (Zeiss C-Apochromat 63x, NA = 1.2) or an oil-immersion 63x objective (Zeiss Plan-Apo-
chromat 63x, NA = 1.4). Z stacks were acquired with a z-step between 0.25-2 mm according to the experiment. For kif1bpst23 ana-
lyses, images of the anterior region of the spinal cord were acquired by aligning the edge of the visual field to the urogenital opening
somite, and the posterior region by aligning the visual field to the last somite in the spinal cord. For manipulations other thane3 Current Biology 28, 1296–1305.e1–e5, April 23, 2018
kif1bpst23, which are not expected to have a region-specific effect, we focused on themiddle spinal cord, by aligning the center of the
visual field to the urogenital opening. The following lengths of spinal cord were sampled in the following data-sets: Figure 1A:448 mm;
Figure 1G 304 mm or as in Figure 3A detailed below; Figure 2H: 236 mm; Figure 3I: 234 mm; Figure 4A: 434 mm. Timelapses of
Tg(olig2:EGFP); Tg(sox10:mRFP) were acquired as before [18]. For drug treatments shown in Figure 3A, embryos were loaded
and oriented for imaging using an LPSampler and VAST BioImager fitted with a 600mm capillary (Union Biometrica). We imaged
the whole length of the embryo (> 3mm) with a Zeiss Axio Examiner D1 equipped with a CSU-X1 spinning confocal scanner, a Zeiss
AxioCam 506 m CCD camera and a Zeiss C-Plan-Apochromat 10x 0.5NA objective, by tiling 5 z stacks per embryo with a z-step of
2-3 mm. Data were presented as density per 100 mm of spinal cord length when necessary to pool datasets with different lengths
sampled, or normalized by dividing each data point by its session’s control average, and graphed as % of the control average
(e.g., Figures 1H and 1I).
Image processing and analysis
Image processing and analysis was performed in Fiji (a distribution of ImageJ). Figure panels were produced using Fiji and Adobe
Illustrator CS8. For figures, maximum-intensity projections of Z stacks were made, and a representative x-y area was cropped.
All zebrafish images and movies represent a lateral view of the spinal cord, anterior to the left and dorsal on top. For most images,
processing included only global change of brightness and contrast; further processing and analysis is as follows.
Cell counts
a grid was superimposed and all EGFP-filled cell bodies (oligodendrocytes) and EGFP-CAAX-surrounded cell bodies not filled with
cytoplasmic EGFP (myelinated cell bodies) were counted through z stacks encompassing the depth of the spinal cord, using the cell
counter plugin in Fiji. An approach based on unbiased stereological methods was used to ensure that each cell was only counted
once. For drug-treated animals (Figure 3A), we counted all dorsal oligodendrocytes and dorsal myelinated cell bodies along the entire
length of the spinal cord in maximum-intensity projections, while blinded to treatment conditions. When data from multiple experi-
mental sessions were pooled, to graph normalized data, we divided each data point by its session’s control (WT or DMSO-treated)
average, and graphed each data point as a percentage of the control average (Figures 3B–3D).
Individual oligodendrocyte morphology
for kif1bp analysis, oligodendrocytes isolated in the field of view with cell bodies clearly positioned in the ventral or dorsal tracts were
considered, and the number of sheaths, their length and their location on dorsal, medial, ventral or motor tracts analyzed throughout
the z stack. For Tg(mbp:hAkt1DD) analysis, only dorsal oligodendrocytes were considered. Analyses were performed while blinded
to genotype.
Electron micrographs
the Photomerge tool in Adobe Photoshop was used first for automatic registration and tiling. Axons containing identifiable neurofila-
ment cross-sectional profiles (10nm), with a roughly circular profile and located in the white matter were traced and measured in
Adobe Photoshop or Fiji and their area was used to determine the corresponding diameter. Tracing was performed while blinded
to genotype.
Individual reticulospinal axons
EGFP+ axons located in the ventral spinal cord with at least two collateral branches and one myelin sheath (tagRFPt-contactin1a
gap) were considered, and axonal length and the number and length of tagRFPt-contactin1a gaps analyzed throughout the Z stack.
Analysis was performed while blinded to genotype.
Very dorsal myelin sheaths
all myelin sheaths that were located above the dorsal most myelinated axon in the dorsal tract of the spinal cord of Tg(mbp:EGFP-
CAAX) transgenic animals were counted and measured through the z stack, while blinded to drug treatment.
Time-lapse
Z stacks were maximum intensity-projected for each time point; the olig2:EGFP channel was registered between time points using
the ‘Register virtual stack slices’ plugin in Fiji, and the ‘Transform virtual stack slices’ plugin was used to apply the same transforma-
tions to the sox10:mRFP channel.
Mouse spinal cord image acquisition and analysis
Imageswere acquired using an Andor Borealis CSU-W1 spinning disk confocal system. Stitched reconstructions of spinal cord hemi-
sectionswere generated in Fiji, and the incidence of wrapped cell bodies (as determined by tight apposition of NeuN+ cell bodies with
MBP throughout individual planes in the z stack) was quantified by a blinded observer. The region of the dorsal horn containing NeuN+
cell bodies (approximately 8,000 – 9,000 mm2) from six cervical spinal cord (C5 – C8) hemisections were analyzed per mouse, and the
pooled medians of hemisections from either Ptenfl/fl/CNP-Cre or Ptenfl/fl animals were compared via a Mann-Whitney U test.
QUANTIFICATION AND STATISTICAL ANALYSES
All graphs and statistical tests were carried out using GraphPad Prism. All data were averaged per biological replicate (N represents
number of animals). Data was tested for normal distribution using D’Agostino-Pearson omnibus test and compared between groups
using a two-tailed unpaired Student’s t test; and the distribution of all data was also compared using the Mann-Whitney U test.
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Mann-Whitney test. Throughout the figures, we indicate p values as follows: no indication or ‘ns’ p > 0.05, ‘*’ p < 0.05, ‘**’ p < 0.01, ‘***’
p < 0.001. Indicated p values are from t test comparison in all graphs where datasets passed the normality test; when data was clearly
not normally distributed (Figures 2D, 4F, and 4K), we indicate the result of theMann-Whitney U test. Throughout the figures, error bars
illustrated mean ± standard deviation (SD), except where noted otherwise. For comparisons of myelinated axon distribution, p values
were corrected for multiple comparisons using the Holm-Sidakmethod. Statistical tests were performed on original data, and p value
results were not changed by transformation of data, i.e., when divided by control average or expressed as density (number per
100mm length of spinal cord). Details of statistical test used, precise p value and N values for each comparison are detailed in
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